^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Nurdati (prolgolimab/nurulimab)

i
Other names: BCD-217, Anti-CTLA-4/Anti-PD-1 FDC, BCD 217, BCD217
Associations
Company:
Biocad
Drug class:
PD1 inhibitor, CTLA4 inhibitor
Related drugs:
Associations